CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP Down After-hours

Today's Daily Dose brings you news about ACADIA's North American License Agreement with Neuren Pharma; upcoming milestones of Akcea; product development agreement between Antares and Pfizer; CryoLife's Q2 results and upbeat outlook; partial clinical hold on Gemphire's Gemcabene, and InspireMD's and Vericel's Q2 financial results.

from RTT - Biotech https://ift.tt/2ALN3W9
via IFTTT